Video Library
Heart Failure
Video Library
Stay informed on the latest in heart failure care by watching experts discuss key topics in the videos below.
Explore All Videos
Overview of the Pathophysiology of HF With LVEF ≥40%
Dr. Muthiah Vaduganathan discusses the pathophysiology of HF with LVEF ≥40% and the shared mechanisms of disease progression with CV and kidney diseases.
Addressing Unmet Needs for Patients With HFpEF
Dr. Biykem Bozkurt reviews the unmet needs and epidemiology of HFpEF and the limited treatment options available for this condition.
Challenges in Diagnosis of HF
The diagnosis of heart failure with preserved ejection fraction (HFpEF) can be more difficult due to patients presenting with a normal LVEF of ≥50%. Clinical scoring systems may be useful to aid in the diagnostic evaluation of suspected HFpEF.
HF Guidelines (Treatment of HF with LVEF >40%)
Management of heart failure with LVEF >40% focuses on symptom management and disease-modifying therapy, lifestyle modifications, device therapy (in select patients), and management of comorbidities.
Exploring the Connection Between HF and CKD
Dr. Javed Butler talks about the connection between heart and kidney diseases and the potential for common therapies to improve patient outcomes.
Review of the Current US Guideline Landscape for HF Management
Dr. Stephen Greene reviews the 2022 AHA/ACC/HFSA HF guidelines, focusing on current treatment recommendations and future potential updates.
Recognizing UACR as a Predictor of CV Risk
Dr. Katharina Schütt discusses the importance of measuring UACR in patients with CKD associated with T2D, as it is a marker for CV risk and HF.
Examining the Prevalence and Impact of HF in CKD
Patients with heart failure and CKD, linked by common risk factors and mechanistic pathways, can experience substantial burden.
HF Patient Experience
Hear what patients with heart failure have to say about their condition.
You are encouraged to report side effects or quality complaints of products to the FDA by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. For Bayer products, you can report these directly to Bayer by clicking here.
This site provides access to balanced and evidence-based medical information related to our therapeutic areas of focus and is intended to serve as a medical resource for US HCPs. This may include investigational compounds or investigational new uses of FDA-approved Bayer products. The information provided is not intended to be promotional or provide medical advice. Please refer to the full Prescribing Information for approved indications, contraindications, warnings and precautions, and adverse events.
